ZEB2 and ovarian carcinoma: A study by Bendroaite et al. confirmed that ZEB2 is the targeted gene for the miR-200 family in ovarian cancer using the luciferase-ZEB2 3′-UTR reporter constructs and miR-200 family expression plasmids [25].